Skip to main content

Table 3 Adjusted Odds Ratio and 95% Confidence Intervals (CI) for logistic regression models predicting intention to screen by women in 5 European countries responding to the survey on mammography screening, 2021 (n = 1180)

From: Factors affecting intention to screen after being informed of benefits and harms of breast cancer screening: a study in 5 European countries in 2021

Components

Model 1a,b

Model 2c,d

 

Neither more nor less likely to participate next time invited/referred for breast cancer screening

More likely to participate next time

invited/referred for breast cancer

screening

Neither more nor less likely to participate next time invited/referred for breast cancer screening

More likely to participate next time invited/referred for breast cancer screening

Adjusted OR

95% CI

Adjusted OR

95% CI

Adjusted OR

95% CI

Adjusted OR

95% CI

Age

 50–59 y

.

.

.

.

.

.

.

.

 60+ y

.

.

.

.

.837

(.458–1.531)

.505

(.274–.931)

Income

 €20,000–€39,999

.

.

.

.

.

.

.

.

  < €19,999

.

.

.

.

1.446

(.663–3.151)

1.145

(.522–2.515)

 €40,000–€59,999

.

.

.

.

1.169

(.456–2.997)

.788

(.303–2.044)

 €60,000–€79,999

.

.

.

.

.742

(.206–2.673)

.419

(.114–1.538)

 €80,000+

.

.

.

.

2.967

(.322–27.361)

2.585

(.276–24.239)

Prefer not to say

.

.

.

.

1.683

(.706–4.012)

1.154

(.479–2.782)

HLS6 Score

.911

(.769–1.078)

.847

(.714–1.004)

.903

(.759–1.073)

.843

(.708–1.004)

Screening History

 Not participated

.

.

.

.

.

.

 

.

 Participated

.812

(.387–1.703)

1.780

(.803–3.947)

.778

(.366–1.657)

1.883

(.833–4.257)

Health Knowledge

 Incorrect

.

.

.

.

.

.

.

.

 Correct

.622

(.302–1.284)

.991

(.472–2.078)

.618

(.298–1.283)

1.061

(.502–2.242)

Social Norm

 Agree

.

.

.

.

.

.

.

.

 Disagree

.323

(.153–.686)

.345

(.162–.734)

.322

(.150–.691)

.351

(.163–.758)

 Unsure

.754

(.364–1.560)

.452

(.216–.946)

.766

(.369–1.594)

.447

(.212–.940

Perceived Behavioural Control

 Easy

.

.

.

.

.

.

.

.

 Difficult

.237

(.103–.544)

.140

(.059–.335)

.217

(.093–.504)

.120

(.049–.290)

 Unsure

.201

(.094–.430)

.142

(.066–.305)

.194

(.090–.421)

.132

(.060–.288)

Perceived Susceptibility

 Unsure

.

.

.

.

.

.

.

.

 Agree

.810

(.215–3.048)

1.877

(.511–6.889)

.864

(.225–3.316)

1.901

(.506–7.138)

 Disagree

.729

(.390–1.364)

.457

(.242–.865)

.696

(.369–1.310)

.435

(.228–.830)

Perceived Barriers

 Disagree

.

.

.

.

.

.

.

.

 Agree

.338

(.166–.692)

.175

(.084–.362)

.347

(.169–.711)

.183

(.088–.382)

 Unsure

.638

(.280–1.454)

.508

(.222–1.161)

.643

(.279–1.481)

.544

(.235–1.259)

  1. a Model 1 result = Negelkerke R2 .201
  2. b Model 1 reference category: Less likely to participate next time invited/referred for breast cancer screening
  3. c Model 2 result = Negelkerke R2 .224
  4. d Model 2 reference category: Less likely to participate next time invited/referred for breast cancer screening